Insulet Corp. is a medical device company ... Garibotto in July 2000 and is headquartered in Acton, MA.

Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief technology officer at the Acton medical device manufacturer.

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, will host ...

Companies valued at more than $10 billion are generally classified as “large-cap” stocks, and Insulet fits this criterion perfectly. Headquartered in Acton, Massachusetts, Insulet also ...

Insulet also recently expanded sensor integrations to include Dexcom G7 for Omnipod 5 users in the U.K. and the Netherlands. Additionally, Insulet is planning to bring Omnipod 5 to five more ...

Insulet experienced a 12% decline in its stock price over the past week following its earnings announcement and corporate guidance. The company reported strong year-over-year sales growth, however ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

Insulet Corporation PODD has witnessed strong momentum in the past year. Shares of the company have risen 62.9% compared with 9.9% growth of the industry during the same time frame. The S&P 500 ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections of insulin to their first automated pump improved users’ time in a ...